CAM
NVAX icon

Capstone Asset Management’s Novavax NVAX Stock Holding History

Capstone Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-515
Closed -$53K – 1795
2013
Q4 		$53K Sell
515
-141
-21% -$9.96K ﹤0.01% 1853
2013
Q3 		$41K Hold
656
– – ﹤0.01% 1986
2013
Q2 		$27K Buy
+656
New +$28.4K ﹤0.01% 1951

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Capstone Asset Management's NVAX Position: Q1 2014 in Review

Capstone Asset Management sold out of Novavax (NVAX) in Q1 2014, closing a stake of 515 shares — an estimated $53K sold.

Capstone Asset Management first reported a position in NVAX in Q2 2013 and held it in 3 quarters. The position peaked at $53K in Q4 2013. 141 funds tracked by Wall St. Rank hold NVAX as of Q1 2014.

  • Capstone Asset Management reported no remaining Novavax position as of Q1 2014 after selling out during the quarter.
  • Capstone Asset Management sold 515 Novavax shares in Q1 2014, an estimated $53K.
  • Capstone Asset Management first reported a position in Novavax in Q2 2013 and held it in 3 quarters.
  • Capstone Asset Management's Novavax position peaked at $53K in Q4 2013.
  • 141 funds tracked by Wall St. Rank held Novavax as of Q1 2014.

Based on Capstone Asset Management's 13F filing for Q1 2014, filed 22 Apr 2014.